VideoInterviewsCannabis

Part #2: Halo Labs Poised to Capitalize on UK Medicinal Cannabis Opportunity

By Shadd Dales On Nov 23, 2020

In Part #2 of our sit down conversation with Halo Labs (NEO: HALO) CEO Kiran Sidhu we talk about their anticipated accelerated growth for 2021 through both acquisition and organically.

With continued growth in California, Nevada and Oregon, Sidhu shifts his attention in the following interview to outline and provide an update on their international business model in Lesotho, Malta and Europe which aims to add $4-5 million in revenue by mid 2021.

In addition to Europe, Halo recent become only one of four distributors in the UK with a Controlled Drug License for medicinal use marijuana with the closing of distributor Canmart Ltd. Sidhu views the UK opportunity to the 80s era in San Francisco, touching on how the UK it has one of the highest per capita marijuana usage in the world.

Related: With Winberry Farms Acquisition, Halo Labs Inc. Could Soon Hold 30 Percent of Oregon’s Cannabis Market

#bidenharris2020 #cannabis #cannabisstocks #marijuana #stockmarket #stocks #uselection

Shadd Dales

Shadd Dales is the Founder and President of The Dales Report and has an extensive background in the business media industry.

His work translates into over 15 years in mainstream media that included roles with BNN Bloomberg, CTV Properties and the iHeart Radio Network.

Shadd is considered one of the leading on air talents in both the cannabis and psychedelic space and has interviewed some of the most notable CEO names in the industry.

Shadd’s vision is to establish a content platform that is equivalent to a mainstream broadcast produced in a format that is relevant for today’s investor.